Zhang Lei, Ding Qian, Liu Cunrui, Sun Yannan, Xie Qiufei, Zhou Yongsheng
Int J Prosthodont. 2016 Mar-Apr;29(2):115-25. doi: 10.11607/ijp.4402.
This systematic review attempted to determine the survival rate of implants placed in bone flaps in jaw rehabilitation and the functional gains and the most common complications related to these implants.
An electronic search was undertaken of PubMed, EMBASE, and CNKI records from 1990 through July 2014. Two independent examiners read the titles and abstracts of the results to identify studies that met the inclusion criteria. Subsequently, the reference lists of the selected publications were hand searched. Descriptive statistics were used to report all data related to the survival rate of implants placed in bone flaps in jaw rehabilitation, the functional gains, and complications.
A total of 20 studies were included for systematic review without repetition. The mean follow-up time after implant placement ranged from 1.75 to 9.5 years. Within the limitations of available studies, the survival rate of implants placed in bone flaps in jaw rehabilitation ranged from 82.4% to 100%. Of the 20 included studies, 15 reported a survival rate higher than 90%. The cumulative survival rate was 93.2%, with the longest follow-up time being 12.9 years. The most common complications related to these implants were peri-implant bone resorption or peri-implant inflammation, and peri-implant soft tissue proliferation. The main factors associated with the survival rate of implants in bone flaps were reported as time of implant placement and radiotherapy. Despite some persistent soft tissue problems and implant loss, most patients reached a satisfactory functional and esthetic outcome, as evaluated by clinical examination and subjectively by the patients at interview. Implant-supported dental prosthetic rehabilitation in reconstructed jaws improved the quality of life in terms of speech, nutrition, oral competence, and facial appearance.
Placement of implants in bone flaps in jaw rehabilitation was demonstrated to be a reliable technique with a high survival rate. Multicentered randomized controlled clinical trials and longer clinical studies should be undertaken in this area.
本系统评价旨在确定用于颌骨修复的骨瓣中种植体的存活率、功能改善情况以及与这些种植体相关的最常见并发症。
对1990年至2014年7月期间的PubMed、EMBASE和中国知网记录进行电子检索。两名独立审查员阅读结果的标题和摘要,以确定符合纳入标准的研究。随后,对所选出版物的参考文献列表进行手工检索。采用描述性统计方法报告与颌骨修复骨瓣中种植体存活率、功能改善及并发症相关的所有数据。
共纳入20项研究进行系统评价,无重复。种植体植入后的平均随访时间为1.75至9.5年。在现有研究的局限性范围内,颌骨修复骨瓣中种植体的存活率为82.4%至100%。在纳入的20项研究中,15项报告存活率高于90%。累积存活率为93.2%,最长随访时间为12.9年。与这些种植体相关的最常见并发症是种植体周围骨吸收或种植体周围炎症以及种植体周围软组织增生。据报道,与骨瓣中种植体存活率相关的主要因素为种植体植入时间和放疗。尽管存在一些持续的软组织问题和种植体丢失,但通过临床检查和患者访谈主观评估,大多数患者达到了满意的功能和美学效果。重建颌骨中种植体支持的牙修复改善了患者在言语、营养、口腔功能和面部外观方面的生活质量。
颌骨修复骨瓣中种植体植入被证明是一种可靠的技术,存活率高。该领域应开展多中心随机对照临床试验和更长时间的临床研究。